Enfusion Inc (NYSE: ENFN) is 7.28% higher on its value in year-to-date trading and has touched a low of $7.83 and a high of $11.80 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ENFN stock was last observed hovering at around $11.16 in the last trading session, with the day’s loss setting it -0.11%.
Currently trading at $11.05, the stock is -1.93% and 0.34% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.16 million and changing -0.99% at the moment leaves the stock 15.67% off its SMA200. ENFN registered 29.69% gain for a year compared to 6-month gain of 35.75%. The firm has a 50-day simple moving average (SMA 50) of $11.0128 and a 200-day simple moving average (SMA200) of $9.55335.
The stock witnessed a -0.36% loss in the last 1 month and extending the period to 3 months gives it a 6.87%, and is -2.13% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.24% over the week and 1.62% over the month.
Enfusion Inc (ENFN) has around 1143 employees, a market worth around $1.43B and $201.61M in sales. Current P/E ratio is 387.72 and Fwd P/E is 29.73. Profit margin for the company is 1.40%. Distance from 52-week low is 41.12% and -6.36% from its 52-week high. The company has generated returns on investments over the last 12 months (3.23%).
with sales reaching $55.08M over the same period.The EPS is expected to grow by 48.59% this year, but quarterly earnings will post 17.68% year-over-year. Quarterly sales are estimated to grow 14.63% in year-over-year returns.
185.0 institutions hold shares in Enfusion Inc (ENFN), with institutional investors hold 101.75% of the company’s shares. The shares outstanding are 94.66M, and float is at 48.84M with Short Float at 1.94%. Institutions hold 96.89% of the Float.
The top institutional shareholder in the company is FTV MANAGEMENT COMPANY, L.P. with over 32.44 million shares valued at $276.39 million. The investor’s holdings represent 35.116 of the ENFN Shares outstanding. As of 2024-06-30, the second largest holder is ICONIQ CAPITAL, LLC with 14.04 million shares valued at $119.62 million to account for 15.1975 of the shares outstanding. The other top investors are BROWN CAPITAL MANAGEMENT LLC which holds 8.57 million shares representing 9.2817 and valued at over $73.05 million, while HHLR ADVISORS, LTD. holds 5.3855 of the shares totaling 4.98 million with a market value of $42.39 million.
Enfusion Inc (ENFN) Insider Activity
The most recent transaction is an insider sale by Bastone Bronwen, the company’s Chief People Officer. SEC filings show that Bastone Bronwen sold 3,126 shares of the company’s common stock on Mar 05 ’25 at a price of $11.38 per share for a total of $35558.0. Following the sale, the insider now owns 0.22 million shares.
Enfusion Inc disclosed in a document filed with the SEC on Mar 05 ’25 that Campobasso Matthew (General Counsel) sold a total of 1,695 shares of the company’s common stock. The trade occurred on Mar 05 ’25 and was made at $11.38 per share for $19281.0. Following the transaction, the insider now directly holds 70946.0 shares of the ENFN stock.
Still, SEC filings show that on Mar 06 ’25, Movchan Oleg (Chief Executive Officer) disposed off 11,452 shares at an average price of $11.39 for $0.13 million. The insider now directly holds 631,847 shares of Enfusion Inc (ENFN).
